Enovis to Participate in Upcoming Investor Conferences
Enovis to Participate in Upcoming Investor Conferences
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company's extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company's shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit .Wilmington, DE, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Enovis Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences:
Delaware州威爾明頓, 2024年11月18日(GLOBE NEWSWIRE) -- Enovis公司(紐約證交所: ENOV), 一家以創新驅動的醫療技術增長公司, 今天宣佈其管理團隊將參加以下投資者會議:
- Jefferies London Healthcare Conference: Matt Trerotola, Chair and Chief Executive Officer, and Ben Berry, Chief Financial Officer, will participate in a fireside chat on Wednesday, November 20th at 12:00 p.m. GMT (7:00 a.m. ET)
-
Evercore 7th Annual HealthCONx Conference: Ben Berry, Chief Financial Officer, will participate in a fireside chat on Wednesday, December 4th at 10:50 a.m. ET.
- Jefferies倫敦醫療保健會議: Matt Trerotola, 主席兼首席執行官, 以及Ben Berry, 致富金融(臨時代碼)，將於11月20日星期三下午12:00 GMt (東部時間7:00 a.m.);進行爐邊聊天.
- Evercore第七屆HealthCONx會議: 致富金融(臨時代碼)Ben Berry, 將於12月4日星期三上午10:50 Et;進行爐邊聊天.
A link to the live audio webcasts, as well as a replay of these events, will be available on the Company's website under the Investors tab at Events and Presentations.
公司網站上的投資者選項卡下的活動與演示中, 將提供這些活動的現場音頻網絡廣播鏈接, 以及這些活動的重播.
ABOUT ENOVIS
關於ENOVIS
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company's extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company's shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit .
Enovis公司（紐約證券交易所：ENOV）是一家以創新爲驅動的醫療科技成長公司，致力於開發在臨床上有差異化的解決方案，以實現更好的患者結果並改變工作流程。在持續改進、全球人才和創新的文化驅動下，公司廣泛的產品、服務和綜合技術範圍推動了骨科及其他領域的積極生活方式。公司的普通股在美國紐約證券交易所上市，股票代碼爲ENOV。有關Enovis的更多信息，請訪問。
Contact:
聯繫方式：
Kyle Rose
Vice President, Investor Relations
Enovis Corporation
investorrelations@enovis.com
Kyle Rose
投資者關係副總裁
Enovis Corporation 公司
investorrelations@enovis.com
譯文內容由第三人軟體翻譯。
